Ticlopidine and thrombotic thrombocytopenic purpura

New England Journal of Medicine

Volumn 337, Issue 17, 1997, Pages 1245-

  Kupfer, Yizhak ^a   Tessler, Sidney ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; LETTER; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; STENT; THROMBOCYTOPENIC PURPURA;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STENTS; TICLOPIDINE;

EID: 0030700195     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710233371717     Document Type: Article

References (4)

1. Schömig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stems. N Engl J Med 1996;334:io84-9.
2. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC. Throm botic thrombocytopenic purpura related to ticlopidine. Lancet 1991;337: 774-6.
3. Kovacs MI, Soong PY, Chin-Yce IH. Thrombotic thrombocytopcnic purpura associated with ticlopidine. Ann Pharmacother 1993;27:1060-1.
4. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. Vol. 18 of Monographs in epidemiology and biostatistics. New York: Oxford University Press, 1991.